U.S. and International Sites participating in QRX003 NS study, Expanding to study QRX003 for additional indications and in younger patient populations Quoin Pharmaceuticals (NASDAQ:QNRX ...
I n a turbulent market environment, QNRX stock has reached a new 52-week low, trading at just $0.42. According to InvestingPro data, while the company maintains a FAIR financial health score and ...
Quoin Pharmaceuticals, Ltd. (QNRX) stock price is 0.31 and Quoin Pharmaceuticals, Ltd. (QNRX) 10-day simple moving average is 0.31. Quoin Pharmaceuticals, Ltd. (QNRX) stock price is 0.31 and Quoin ...
(RTTNews) - Quoin Pharmaceuticals, Inc. (QNRX), a clinical-stage specialty pharmaceutical company, on Thursday, announced additional clinical data supporting the efficacy of its investigational ...
1 Day QNRX 7.41% DJIA -0.03% Russell 2K 0.37% Health Care/Life Sciences -0.88% ...
Analyst Naz Rahman from Maxim Group reiterated a Buy rating on Quoin Pharmaceuticals (QNRX – Research Report) and keeping the price target at $2.00. Naz Rahman has given his Buy rating due to a ...
ASHBURN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty ...
(RTTNews) - Quoin Pharmaceuticals, Ltd. (QNRX) Tuesday announced positive interim clinical data from its ongoing Investigator Pediatric Netherton Syndrome clinical study using QRX003. The data ...